Dechra US

Dechra US Dechra is a global leader in veterinary specialty care, dedicated to the sustainable improvement of animal health and welfare.

In order to keep the dialogue appropriate and relevant, all posted material must comply with Facebook’s Terms of Use, as well as our guidelines. PLEASE NOTE: For any FDA-approved product, we must adhere to FDA guidance and protocols regarding risk awareness, on-label discussions, and submitting promotional material. When we respond to users’ responses, it will often not be immediate, as each will

need to go through our internal legal, regulatory, and scientific review prior to being posted. If the purpose of your posts is for product-related questions or that you wish to report an adverse event/reaction associated with a Dechra product, please contact our Technical Services at (866) 933-2472. Posts, photos and other material submitted by fans does not necessarily reflect the opinions of Dechra. We reserve the right to remove any content that falls into one or more of the following categories:

• inappropriate/graphic language or visual images
• sexually explicit language or obscene jokes
• profanities/racial slurs
• obscene language related to race, color, gender, sexual orientation, religion, national origin, age, disability or marital status
• threatening language
• post that is spam, advertising of outside sources or links, or a violation of intellectual property rights or law.
• links to inappropriate content (as described herein)
• personal information of another fan or of a Dechra employee
• product usage in ways other than directed on product label
• product usage instructions not provided by a Dechra representative
• comments regarding specific individuals within the company
• posts about competitors’ products
• anything from a non-approved poster that includes a link

The text, graphics, images, and other material (“Content”) posted on the Dechra social media properties are for informational purposes only. The Content, offered on the pages we support and posts we publish and share are to educate consumers on health care and medical issues that may affect their pet’s daily lives. The Content is not intended to be a substitute for veterinarian medical advice, diagnosis, or treatment. Always seek the advice of your veterinarian or other qualified animal health care provider with any questions you may have regarding a companion animal’s medical condition or any healthcare matters. Dechra reserves the right to evaluate posts on an individual basis and immediately ban anyone who violates our standards.

06/30/2026

New course alert! 🚨

“PPID in Horses: Essential Steps for Diagnosis, Treatment, and Lifelong Management” with Dr. Katarzyna Dembek is now available on Dechra Academy.

Get expert guidance on:

✅ Accurate diagnosis
✅ Effective treatment strategies
✅ Long-term monitoring and care

Start learning on your time: https://brnw.ch/21x3M4f

Think you know skin lesions?Dive into Dechra Academy’s “Derm Detective: Name that Skin Lesion!” and challenge your derma...
06/17/2026

Think you know skin lesions?

Dive into Dechra Academy’s “Derm Detective: Name that Skin Lesion!” and challenge your dermatology diagnostic skills with case-based learning led by Dr. Rusty Muse (DVM, DACVD, MANZCVS).

Find out at:https://brnw.ch/21x3qFd

Don’t miss our upcoming live webinar, “Current Approaches to Procedural Sedation in Dogs and Cats” with Dr. Lisa Ebner. ...
06/16/2026

Don’t miss our upcoming live webinar, “Current Approaches to Procedural Sedation in Dogs and Cats” with Dr. Lisa Ebner. In this lecture, Dr. Ebner will cover up to date non-pharmacologic and pharmacologic approaches for dogs and cats presenting to the veterinary care setting for procedural sedation. A review of terminology, drug mechanisms, and helpful equipment and supplies will also be discussed.

Attendees will receive 1 hour of RACE-approved credit.

🗓️ Date: Tuesday, June 23, 2026
🕒 Time: 7:00 p.m. EDT

Sign up for your spot at: https://brnw.ch/21x3oCY.

Intended for veterinary professionals only.

Dechra would like to shine the spotlight on Heartland Therapeutic Riding, Inc. one of this year’s top recipients in Dech...
06/12/2026

Dechra would like to shine the spotlight on Heartland Therapeutic Riding, Inc. one of this year’s top recipients in Dechra’s employee-led giving program.

Through equine-assisted services, Heartland is helping people with disabilities improve physical and emotional well-being, bringing to life the human-animal bond.

Learn more about their impact: https://brnw.ch/21x3iuc

Acute kidney injury (AKI) in cats is a complex and emergent condition that requires rapid recognition, careful diagnosti...
06/10/2026

Acute kidney injury (AKI) in cats is a complex and emergent condition that requires rapid recognition, careful diagnostics, and intensive nursing care. While veterinarians guide diagnosis and treatment decisions, veterinary technicians play a critical role in nursing care. Join Caitlin Dutcher-Lundy (RVT, VTS (CP-Feline)) for the upcoming live webinar, “Critical Kidneys: Technician-focused Care for Cats with Acute Kidney Injury.” In this webinar, she will explore pathophysiology, common causes, AKI grading and relation to chronic kidney disease (CKD), nursing strategies, and caregiver education.

Attendees will receive 1 hour of RACE-approved credit

🗓️ Date: Wednesday, June 17, 2026
🕒 Time: 7:00 p.m. EDT

Register at https://brnw.ch/21x3fms.

Intended for veterinary professionals only.

Think you’ve got a sharp eye for derm concerns?Put your skills to the test with Dechra Academy’s “Derm Detective: Name T...
06/09/2026

Think you’ve got a sharp eye for derm concerns?

Put your skills to the test with Dechra Academy’s “Derm Detective: Name That Skin Lesion!” featuring Dr. Rusty Muse, DVM, DACVD, MANZCVS.

Real-world cases. Diagnostic challenges. Education on your own time.

Start diagnosing at: https://brnw.ch/21x3drO

We’re proud to recognize Muttville Senior Dog Rescue as a top recipient of Dechra’s Charitable Giving Program.By rescuin...
06/05/2026

We’re proud to recognize Muttville Senior Dog Rescue as a top recipient of Dechra’s Charitable Giving Program.

By rescuing and rehoming senior dogs, Muttville is improving both animal welfare and adopters’ lives through companionship and care.

Discover their story: https://brnw.ch/21x385t

Are you itching to level up your dermatology knowledge? You won’t want to miss our upcoming LIVE webinar, “Canine Atopic...
06/03/2026

Are you itching to level up your dermatology knowledge? You won’t want to miss our upcoming LIVE webinar, “Canine Atopic Dermatitis—Treatment Options for All Varieties of Cases” with Dr. Jason Pieper. In this session, Dr. Pieper will discuss the pathogenesis and diagnosis of canine atopic dermatitis, including clinical signs and breed-specific differences. He will also cover a variety of treatment options and their potential benefits and adverse events.

Attendees will receive 1 hour of RACE-approved credit.

🗓️ Date: Tuesday, June 9, 2026
🕒 Time: 8:00 p.m. EDT

Register for your spot at: https://brnw.ch/21x34cN.

Intended for veterinary professionals only.

We’re proud to share that Dechra is donating nearly $80,000 to two dozen nonprofit organizations through our employee-le...
06/02/2026

We’re proud to share that Dechra is donating nearly $80,000 to two dozen nonprofit organizations through our employee-led giving program.

Learn more about these organizations and our commitment to giving back: https://brnw.ch/21x31Jr

Heartland Therapeutic Riding, Inc.
Muttville Senior Dog Rescue

Dechra is pleased to announce the FDA approval of CosACTHen® (cosyntropin injection), the first and only cosyntropin spe...
05/27/2026

Dechra is pleased to announce the FDA approval of CosACTHen® (cosyntropin injection), the first and only cosyntropin specifically indicated for the evaluation of adrenal function in dogs.

Learn more: https://brnw.ch/21x2SEV

Package Insert: https://brnw.ch/21x2SEW

IMPORTANT SAFETY INFORMATION: As with all drugs, side effects may occur. For intravenous or intramuscular use in dogs only. Do not use Cosacthen in dogs that have previously had a hypersensitivity reaction to cosyntropin. The following adverse events were reported voluntarily during postapproval use of Cosacthen in dogs in foreign markets: lethargy, anxiety, muscle tremor/weakness, abdominal pain, anorexia, diarrhea, injection site pain/bruising, lameness, and hypersensitivity reactions. The safe use of Cosacthen has not been evaluated in breeding, pregnant, or lactating dogs. Not for use in humans. People with known hypersensitivity to cosyntropin or ACTH should avoid contact with the product. Pregnant and breastfeeding women should take care to avoid accidental self-injection. In case of accidental self-injection, seek medical advice immediately. If skin contact occurs, wash affected area with soap and water. Refer to the prescribing information for complete details or visit www.dechra‐https://brnw.ch/21x2SET.

This communication may contain information about a product that is otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for you accessing such information that may not comply with any legal process, regulation, registration, or usage in the country of your origin.

Address

One Marina Park Drive, Suite 1300
Overland Park, KS
02210

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Alerts

Be the first to know and let us send you an email when Dechra US posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share